• about
  • DC IMMUNOTHERAPY
    • THE PRINCIPLE
    • ABOUT MESOPHER
    • PUBLICATIONS
  • pipeline
    • PLEURAL MESOTHELIOMA
    • PERITONEAL MESOTHELIOMA
    • PANCREATIC CANCER
  • partners & investors
  • news
  • contact
  1. Home
  2. Amphera news
  3. EMA Orphan Designation granted

EMA Orphan Designation granted

09 Apr 2014

The European Commission granted orphan designation (EU/3/13/1229, 16 January 2014) to Amphera for her innovative immunotherapy for the treatment of malignant mesothelioma.

Previous Amphera is awarded first Red MedTechVentures loan of 350.000 Euro
Next FDA Orphan Designation granted
  • disclaimer
  • privacy policy

© 2019 Scicomvisuals, all rights reserved.